Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 86901-86950 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05162391
Inflammation in Methamphetamine and STIs (IMSTI)
NA
Active, not recruiting
30 participants
Started: May 31, 2022 · Completed: Jun 30, 2027
3 conditions
1 sponsor
1 location
NCT05045157
Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders
NA
Recruiting
90 participants
Started: May 31, 2022 · Completed: May 31, 2027
1 condition
1 sponsor
4 locations
NCT05321316
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
NA
Recruiting
20 participants
Started: May 31, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05357157
Electroacupuncture Pain Treatment, Mechanical Hyperalgesia, Quality of Life & Expression of Mu+ B Cells in Fibromyalgia
N/A
Recruiting
80 participants
Started: May 31, 2022 · Completed: Dec 1, 2026
4 conditions
2 sponsors
1 location
NCT05232006
PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations Carriers
PHASE2
Not yet recruiting
12 participants
Started: May 31, 2022 · Completed: May 31, 2030
1 condition
1 sponsor
0 locations
NCT05371977
Deep Sclerectomy Versus Trabeculectomy in Normal Tension Glaucoma
NA
Recruiting
80 participants
Started: May 31, 2022 · Completed: May 31, 2029
1 condition
1 sponsor
1 location
NCT05378464
Adoptive T Cell Therapy Following HER2-Pulsed Dendritic Cell Vaccine & Pepinemab /Trastuzumab in Patients w/ Metastatic HER2+ Breast Cancer
PHASE1
Recruiting
28 participants
Started: May 31, 2022 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT05482945
CardioPulmonary Resuscitation With Argon (CPAr) Trial
PHASE2
Recruiting
120 participants
Started: May 30, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
9 locations
NCT05371730
A Trial to Evaluate the Safety and Efficacy of NK Cells in Subjects With Myelodysplastic Syndromes
EARLY_PHASE1
Not yet recruiting
15 participants
Started: May 30, 2022 · Completed: Apr 30, 2026
1 condition
2 sponsors
0 locations
NCT05315167
A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
267 participants
Started: May 30, 2022 · Completed: Nov 15, 2027
2 conditions
1 sponsor
5 locations
NCT06286644
Hop Compounds on the Immune System (VH)
NA
Recruiting
14 participants
Started: May 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05030155
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients with Eosinophilic Granulomatosis with Polyangiitis (E-merge)
PHASE3
Active, not recruiting
100 participants
Started: May 30, 2022 · Completed: Nov 30, 2025
1 condition
3 sponsors
1 location
NCT05701969
Effect of Melatonin on Sleep Patterns of Resident Trainees During Night Float Shift
EARLY_PHASE1
Recruiting
50 participants
Started: May 30, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05286333
Identification of Risk Factors for Recurrence of Low Back Pain and Occupational Repercussions
N/A
Recruiting
225 participants
Started: May 30, 2022 · Completed: Mar 31, 2026
1 condition
2 sponsors
1 location
NCT05277168
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
PHASE1/PHASE2
Recruiting
83 participants
Started: May 30, 2022 · Completed: May 30, 2026
1 condition
1 sponsor
29 locations
NCT05303896
Investigating Myocardial Remodelling in the Failing Human Heart
N/A
Recruiting
200 participants
Started: May 30, 2022 · Completed: Jul 31, 2030
1 condition
1 sponsor
1 location
NCT05173155
Comparison of Direct Anterior Approach vs. Lateral Hemiarthroplasty for Femoral Neck Fracture Repair
NA
Recruiting
120 participants
Started: May 30, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
1 location
NCT04876131
Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children
PHASE4
Recruiting
452 participants
Started: May 30, 2022 · Completed: May 16, 2028
3 conditions
2 sponsors
5 locations
NCT05335018
GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma
PHASE2
Active, not recruiting
76 participants
Started: May 30, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT05057403
UK Imaging Diabetes Study Seeing Diabetes Clearly
N/A
Enrolling by invitation
1,000 participants
Started: May 30, 2022 · Completed: Jun 30, 2034
1 condition
2 sponsors
1 location
NCT04869007
The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction
N/A
Recruiting
250 participants
Started: May 30, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
9 locations
NCT05397431
A Survey of Lanadelumab in Participants with Hereditary Angioedema
N/A
Recruiting
100 participants
Started: May 30, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT05186974
Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)
PHASE2
Active, not recruiting
193 participants
Started: May 30, 2022 · Completed: Feb 28, 2026
1 condition
2 sponsors
101 locations
NCT05387681
Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric
PHASE2
Not yet recruiting
35 participants
Started: May 30, 2022 · Completed: Dec 30, 2025
3 conditions
1 sponsor
0 locations
NCT05183646
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
PHASE3
Recruiting
286 participants
Started: May 30, 2022 · Completed: Dec 31, 2029
1 condition
1 sponsor
220 locations
NCT06059469
PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.
PHASE2
Recruiting
20 participants
Started: May 30, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05622721
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs
N/A
Recruiting
200 participants
Started: May 30, 2022 · Completed: May 1, 2026
4 conditions
2 sponsors
1 location
NCT04683575
Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma
PHASE4
Not yet recruiting
5,000 participants
Started: May 30, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT05395819
Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis
NA
Recruiting
40 participants
Started: May 30, 2022 · Completed: May 30, 2026
1 condition
3 sponsors
8 locations
NCT05366478
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
PHASE1
Recruiting
15 participants
Started: May 30, 2022 · Completed: May 30, 2029
3 conditions
1 sponsor
1 location
NCT06891053
Studio TIARA: Alessitimia ed Emicrania Cronica
N/A
Enrolling by invitation
350 participants
Started: May 30, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05056701
Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care
NA
Recruiting
400 participants
Started: May 30, 2022 · Completed: May 30, 2037
1 condition
1 sponsor
2 locations
NCT05518253
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
PHASE1
Recruiting
30 participants
Started: May 30, 2022 · Completed: May 30, 2027
5 conditions
2 sponsors
1 location
NCT05101070
S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2
Recruiting
274 participants
Started: May 30, 2022 · Completed: Apr 16, 2027
1 condition
2 sponsors
8 locations
NCT05311709
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
PHASE2
Recruiting
100 participants
Started: May 30, 2022 · Completed: Mar 1, 2025
7 conditions
9 sponsors
1 location
NCT05549167
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)
PHASE3
Recruiting
117 participants
Started: May 30, 2022 · Completed: Dec 30, 2029
1 condition
1 sponsor
1 location
NCT05411133
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
PHASE1
Recruiting
68 participants
Started: May 30, 2022 · Completed: May 31, 2026
9 conditions
1 sponsor
3 locations
NCT05076175
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
PHASE2/PHASE3
Recruiting
120 participants
Started: May 30, 2022 · Completed: Aug 14, 2031
1 condition
1 sponsor
89 locations
NCT05372445
Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention
NA
Recruiting
480 participants
Started: May 30, 2022 · Completed: Dec 31, 2025
3 conditions
6 sponsors
1 location
NCT06105242
Biological Sex and CTEPH-related RV Dysfunction and Recovery (BIOSPHeRe)
N/A
Recruiting
10 participants
Started: May 30, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05392712
Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis
NA
Recruiting
430 participants
Started: May 30, 2022 · Completed: Dec 30, 2024
1 condition
14 sponsors
1 location
NCT05428514
Evaluating the Impact of Emergency Maternity Housing
NA
Recruiting
1,048 participants
Started: May 30, 2022 · Completed: Dec 1, 2025
2 conditions
6 sponsors
1 location
NCT05250843
TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
PHASE2/PHASE3
Recruiting
90 participants
Started: May 30, 2022 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT05169866
Nifekalant Versus Amiodarone in New-Onset Atrial Fibrillation After Cardiac Surgery
PHASE3
Recruiting
274 participants
Started: May 29, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT06190860
Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers
NA
Recruiting
16 participants
Started: May 29, 2022 · Completed: Mar 31, 2024
3 conditions
2 sponsors
2 locations
NCT05257577
Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)
N/A
Active, not recruiting
220 participants
Started: May 28, 2022 · Completed: Mar 30, 2027
6 conditions
4 sponsors
4 locations
NCT05922969
Safety of Low PEEP Maneuvers During ARDS Management
N/A
Recruiting
50 participants
Started: May 28, 2022 · Completed: Nov 30, 2024
2 conditions
2 sponsors
1 location
NCT05521061
The Effect of Human Milk Oligosaccharides in Children With Type 1 Diabetes Mellitus
NA
Recruiting
111 participants
Started: May 28, 2022 · Completed: Dec 31, 2024
2 conditions
3 sponsors
1 location
NCT05864170
the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia
EARLY_PHASE1
Recruiting
3 participants
Started: May 27, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05397132
Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies
N/A
Recruiting
50 participants
Started: May 27, 2022 · Completed: Nov 1, 2026
1 condition
3 sponsors
1 location
Previous
1
More pages
1736
1737
1738
1739
1740
1741
1742
More pages
2369
Next